SCHEMBL3564056

SCHEMBL3564056

Cc1ccc(S(=O)(=O)Nc2cccc(CCc3ccc(C(=O)O)cc3)c2)c(C)c1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.54
HPGD P15428 2/20 0.50
HSD17B10 Q99714 1/20 0.50
IDH1 O75874 2/20 0.49
PTPN5 P54829 1/20 0.48
CYP26A1 O43174 1/20 0.47
WDR5 P61964 1/20 0.47
GFER P55789 2/20 0.46
POLB P06746 1/20 0.46
MAPT P10636 1/20 0.46
ALOX12 P18054 1/20 0.46
FABP4 P15090 1/20 0.46
KMT2A Q03164 2/20 0.45
LIMK1 P53667 1/20 0.45
LIMK2 P53671 1/20 0.45
THRB P10828 1/20 0.45
MEN1 O00255 1/20 0.45
GAA P10253 1/20 0.45
AKR1C3 P42330 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3552657 0.92 ALDH1A1 (0.55) ALDH1A1HPGDHSD17B10IDH1PTPN5
SCHEMBL3561699 0.90 ALDH1A1 (0.59) ALDH1A1HPGDHSD17B10PTPN5CYP26A1
SCHEMBL3561353 0.89 ALDH1A1 (0.54) ALDH1A1HPGDHSD17B10PTPN5CYP26A1
SCHEMBL3558811 0.86 MAPT (0.53) ALDH1A1IDH1GFERPOLBMAPT
SCHEMBL3556021 0.85 KDM1A (0.59) ALDH1A1GFERPOLBKMT2ALIMK1
SCHEMBL3555575 0.84 MEN1 (0.57) ALDH1A1HPGDMAPTKMT2ALIMK1
SCHEMBL3561354 0.84 ALDH1A1 (0.58) ALDH1A1HPGDHSD17B10IDH1PTPN5
SCHEMBL3559534 0.83 SLC16A3 (0.64) ALDH1A1IDH1POLBMAPTKMT2A
SCHEMBL3551155 0.81 HTR6 (0.46) ALDH1A1IDH1WDR5POLBMAPT
SCHEMBL3557287 0.81 SLC16A3 (0.64) ALDH1A1HPGDHSD17B10GFERMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7816397-B2 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes MERCK PATENT GMBH (DE) 2010-10-19 US claimed
US-20080045483-A1 Phenylcarboxylic Acid Derivatives and Use Thereof for the Treatment of Diabetes MERCK PATENT GMBH (DE) 2008-02-21 US claimed
US-7816397-B2 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes MERCK PATENT GMBH (DE) 2010-10-19 US disclosed
US-20080045483-A1 Phenylcarboxylic Acid Derivatives and Use Thereof for the Treatment of Diabetes MERCK PATENT GMBH (DE) 2008-02-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080045483-A1 Phenylcarboxylic Acid Derivatives and Use Thereof for the Treatment of Diabetes SLC5A1, ALDH7A1, ASS1 ALDH1A1 61/4885HPGD 389/4885HSD17B10 236/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.